DNDi has closely followed the negotiations of the WHO Pandemic Agreement, with special attention to the area of research and development (Article 9) and how these provisions may help or hinder addressing the key issue of lack of equitable access to treatments, vaccines, diagnostics, and other health tools. The revised draft text was circulated on 18 April and will be considered by Member States in what should be the final round of negotiations to begin on 29 April.
This briefing sets out DNDi’s comments and recommendations for the Proposal.
